Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 15.3B | 16.5B | 23.0B | 18.6B |
Cost of revenue | -1.0B | 2.3B | 8.6B | 3.0B |
Gross profit | 16.3B | 14.2B | 14.4B | 15.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 8.7B | 6.4B | 6.1B | 5.6B |
Operating income | 3.2B | 3.9B | 4.3B | 6.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2.9B | 3.5B | 3.6B | 3.5B |
Other income expense | — | — | — | — |
Pretax income | 871M | 767M | 1.8B | 4.1B |
Tax provision | 440M | 445M | -519M | 1.0B |
Net income | 431M | 322M | 2.3B | 3.1B |
Basic EPS | — | 0.4 | 4.7 | 5.8 |
Diluted EPS | — | 0.4 | 4.7 | 5.8 |
Basic average shares | — | 431.7M | 408.9M | 401.0M |
Diluted average shares | — | 431.7M | 408.9M | 401.0M |
EBITDA | 5.9B | 6.3B | 7.4B | 9.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | -181M | -145M | -424M | -744M |
Preferred stock dividends | 0 | 0 | 0 | 0 |